Rapid Dose Therapeutics Corp. RDTCF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.03% | 37.64% | -35.74% | -16.92% | 56.20% |
| Total Depreciation and Amortization | 2.10% | -5.40% | -8.01% | 3.57% | 128.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 328.57% | -92.97% | 34.20% | 48.56% | -53.43% |
| Change in Net Operating Assets | -80.45% | 2,092.82% | 164.16% | 58.38% | -123.44% |
| Cash from Operations | -92.64% | 328.10% | -0.05% | 38.55% | -9,812.50% |
| Capital Expenditure | -- | -- | -- | -- | 85.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 85.00% |
| Total Debt Issued | 100.60% | -787.66% | 37.63% | 133.93% | -- |
| Total Debt Repaid | 85.54% | -576.92% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.73% | -1,186.52% | 13.77% | -45.16% | 2,821.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 199.35% | -- | -- |
| Net Change in Cash | 103.24% | -198.47% | 256.40% | -225.27% | 372.59% |